These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17786037)

  • 21. Immune response to simulated postexposure rabies booster vaccinations in volunteers who received preexposure vaccinations.
    Kositprapa C; Limsuwun K; Wilde H; Jaijaroensup W; Saikasem A; Khawplod P; Kri-aksorn U; Supich C
    Clin Infect Dis; 1997 Sep; 25(3):614-6. PubMed ID: 9314448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intradermal pre-exposure rabies immunisation in New Zealand.
    Shaw MM; Leggat PA; Williams ML
    Travel Med Infect Dis; 2006 Jan; 4(1):29-33. PubMed ID: 16887722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody response of cattle to vaccination with commercial modified live rabies vaccines in Guatemala.
    Gilbert A; Greenberg L; Moran D; Alvarez D; Alvarado M; Garcia DL; Peruski L
    Prev Vet Med; 2015 Jan; 118(1):36-44. PubMed ID: 25466762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody persistence, 32 years after post-exposure prophylaxis with human diploid cell rabies vaccine (HDCV).
    Fayaz A; Simani S; Janani A; Farahtaj F; Biglari P; Howeizi N; Eslami N
    Vaccine; 2011 May; 29(21):3742-5. PubMed ID: 21458608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Revision of the Thai Red Cross intradermal rabies post-exposure regimen by eliminating the 90-day booster injection.
    Khawplod P; Wilde H; Sirikwin S; Benjawongkulchai M; Limusanno S; Jaijaroensab W; Chiraguna N; Supich C; Wangroongsarb Y; Sitprija V
    Vaccine; 2006 Apr; 24(16):3084-6. PubMed ID: 16494972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity of rabies postexposure booster injections in subjects who had previously received intradermal preexposure vaccination.
    Jaijaroensup W; Limusanno S; Khawplod P; Serikul K; Chomchay P; Kaewchomphoo W; Tantawichien T; Wilde H
    J Travel Med; 1999 Dec; 6(4):234-7. PubMed ID: 10575171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine.
    Briggs DJ; Banzhoff A; Nicolay U; Sirikwin S; Dumavibhat B; Tongswas S; Wasi C
    Bull World Health Organ; 2000; 78(5):693-8. PubMed ID: 10859864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preexposure immunization with intradermal human diploid cell rabies vaccine. Risks and benefits of primary and booster vaccination.
    Bernard KW; Mallonee J; Wright JC; Reid FL; Makintubee S; Parker RA; Dwyer DM; Winkler WG
    JAMA; 1987 Feb; 257(8):1059-63. PubMed ID: 3806894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effectiveness of intradermal pre-exposure rabies vaccination in an Australian travel medicine clinic.
    Lau C; Sisson J
    J Travel Med; 2002; 9(6):285-8. PubMed ID: 12962581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity study of abbreviated rabies preexposure vaccination schedules.
    Khawplod P; Wilde H; Benjavongkulchai M; Sriaroon C; Chomchey P
    J Travel Med; 2007; 14(3):173-6. PubMed ID: 17437473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pre-exposure rabies vaccination using purified chick embryo cell rabies vaccine intradermally is immunogenic and safe.
    Kamoltham T; Thinyounyong W; Phongchamnaphai P; Phraisuwan P; Khawplod P; Banzhoff A; Malerczyk C
    J Pediatr; 2007 Aug; 151(2):173-7. PubMed ID: 17643772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rabies Antibody Response After Booster Immunization: A Systematic Review and Meta-analysis.
    Langedijk AC; De Pijper CA; Spijker R; Holman R; Grobusch MP; Stijnis C
    Clin Infect Dis; 2018 Nov; 67(12):1932-1947. PubMed ID: 29788204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity of purified vero cell rabies vaccine used in the treatment of fox-bite victims in India.
    Matha IS; Salunke SR
    Clin Infect Dis; 2005 Feb; 40(4):611-3. PubMed ID: 15712086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rabies antibody seroprotection rates among travelers in Nepal: "rabies seroprotection in travelers".
    Ranney M; Partridge R; Jay GD; Rozzoli DE; Pandey P
    J Travel Med; 2006; 13(6):329-33. PubMed ID: 17107424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative evaluation of immunogenicity, reactogenecity and safety of purified chick embryo cell rabies vaccine and neural tissue rabies vaccine.
    Deshpande AK; Londhe VA; Akarte S; Briggs D
    J Assoc Physicians India; 2003 Jul; 51():655-8. PubMed ID: 14621031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen.
    Madhusudana SN; Sanjay TV; Mahendra BJ; Suja MS
    Int J Infect Dis; 2004 May; 8(3):175-9. PubMed ID: 15109593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity and safety of purified chick-embryo cell rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese children 6 to 17 years old and adults over 50 years: a randomized open-label study.
    Li R; Li Y; Wen S; Wen H; Nong Y; Mo Z; Xie F; Pellegrini M
    Hum Vaccin Immunother; 2015; 11(2):435-42. PubMed ID: 25692350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune response to rabies booster vaccination in subjects who had postexposure treatment more than 5 years previously.
    Naraporn N; Khawplod P; Limsuwan K; Thipkong P; Herzog C; Glueck R; Tantawichien T; Wilde H
    J Travel Med; 1999 Jun; 6(2):134-6. PubMed ID: 10381966
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on Japanese-produced chick embryo cell culture rabies vaccines.
    Arai YT; Ogata T; Oya A
    Am J Trop Med Hyg; 1991 Feb; 44(2):131-4. PubMed ID: 2012255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intradermal rabies pre-exposure vaccination schedules in older travellers: comparison of immunogenicity post-primary course and post-booster.
    Furuya-Kanamori L; Ramsey L; Manson M; Gilbert B; Lau CL
    J Travel Med; 2020 Nov; 27(7):. PubMed ID: 31943042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.